The effect of P2 receptor antagonists and ATPase inhibition on sympathetic purinergic neurotransmission in the guinea-pig isolated vas deferens

British Journal of Pharmacology

Volumn 129, Issue 6, 2000, Pages 1089-1094

  Sneddon, P ^a   Westfall, T D ^a   Todorov, L D ^b   Mihaylova Todorova, S ^b   Westfall, D P ^b   Nickel, P ^c   Kennedy, C ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

ARL 67156; ATP; NF023; Nucleoside triphosphatase; P 5 P; PPADS; Purinergic; Vas deferens

Indexed keywords

ADENOSINE TRIPHOSPHATASE; BETA,GAMMA DIBROMOMETHYLENE 6 N,N DIETHYLADENOSINE TRIPHOSPHATE; NF 023; PURINERGIC RECEPTOR BLOCKING AGENT; PYRIDOXAL 5 PHOSPHATE; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE DEPOLARIZATION; FLUOROMETRY; GUINEA PIG; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MICROELECTRODE; MUSCLE FIBER MEMBRANE STEADY POTENTIAL; NERVE STIMULATION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; SMOOTH MUSCLE FIBER MEMBRANE POTENTIAL; SYMPATHETIC NERVE; VAS DEFERENS;

EID: 0034061925     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703163     Document Type: Article

References (29)

1. AMOBI, N. & SMITH, I.C. (1990). Effects of α,β-methyleneATP on biphasic responses of rat vas deferens. Eur. J. Pharmacol., 133, 75-82.
2. BÜLTMANN, R., WITTENBURG, H., PAUSE, B., KURZ, G., NICKEL, P. & STARKE, K. (1996). P2-receptor antagonists; III. Blockade of P2-receptor subtypes and ecto-nucleotidases by compounds related to suramin. Naunyn-Schmiedeberg's Arch. Pharmacol., 354, 498-504.
3. BURNSTOCK, G. (1972). Purinergic nerves. Pharmacol. Rev., 24, 509-581.
4. BURNSTOCK, G. (1990). Purinergic mechanisms. Annals. N.Y. Acad. Sci., 603, 1-17.
5. CRACK, B.E., POLLARD, C.E., BEUKERS, M.W., ROBERTS, S.M., HUNT, S.F., INGALL, A.H., MCKECHNIE, K.C.W., UZERMAN, A.P. & LEFF, P. (1995). Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto-ATPase. Br. J. Pharmacol., 114, 475-481.
6. EVANS, R.J., LEWIS, C., BUELL, G., VALERA, S., NORTH, R.A. & SURPRENANT, A. (1995). Pharmacological characterisation of heterologously expressed ATP-gated cation channels (P2X purinoceptors). Mol. Pharmacol., 48, 178-183.
7. HARPER, S., WEBB, T.E., CHARLTON, S.J., NG, L.L. & BOARDER, M.R. (1998). Evidence that P2Y4 nucleotide receptors are involved in the regulation of rat aortic smooth muscle cells by UTP and ATP. Br. J. Pharmacol., 124, 703-710.
8. KHAKH, B.S., MICHEL, A.D. & HUMPHREY, P.P.A. (1995). Inhibition of ectoATPase and CaATPase in rat vas deferens by P2-purinoceptor antagonists. Br. J. Pharmacol., 115, 2P.
9. LAMBRECHT, G., (1996). Design and pharmacology of selective P2-purinoceptor antagonists. J. Auton. Pharmacol., 16, 341-344.
10. 2X-purinoceptor antagonist, in the guinea-pig isolated vas deferens. Br. J. Pharmacol., 111, 913-917.
11. NICKEL, P., HAACK, H.J., WIDJAJA, H., ARDANUY, C., GURGEL, D., DÜWEL, H., LOEWE, H. & RAETHER, W. (1986). Potentielle filarizide. Arzneim-Forsch./Drug Res., 36, 1153-1157.
12. PLESNER, L. (1995). Ecto-ATPases: identities and functions. Int. Rev. Cytol., 158, 141-214.
13. SNEDDON, P. (1992). Suramin inhibits excitatoryjunction potentials in guinea-pig isolated vas deferens. Br. J. Pharmacol., 107, 101-103.
14. SNEDDON, P. & BURNSTOCK, G. (1984). Inhibition of excitatory junction potentials in guinea-pig vas deferens by α,β-methyleneATP: Further evidence for ATP and noradrenaline as cotransmitters. Eur. J. Pharmacol., 100, 85-92.
15. SNEDDON, P., MCLAREN, G.J. & KENNEDY, C. (1996). Purinergic cotransmission: sympathetic nerves. Seminars in Neurosci., 8, 201-206.
16. 1-purinoceptors. Eur. J. Pharmacol., 105, 293-299.
17. SNEDDON, P. & WESTFALL, D.P. (1984). Pharmacological evidence that adenosine triphosphate and noradrenaline are co-transmitters in the guinea-pig vas deferens. J. Physiol., 347, 561-580.
18. SNEDDON, P., WESTFALL, D.P. & FEDAN, J.S. (1982). Cotransmitters in the motor nerves of the guinea-pig vas deferens: electrophysiological evidence. Science, 218, 693-695.
19. SNEDDON, P., WESTFALL, T.D., TODOROV, L.D., MIHAYLOVA-TODOROVA, S., KENNEDY, C. & WESTFALL, D.P. (1997). The effect of P2-receptor antagonists and ATPase inhibition on sympathetic purinergic neurotransmission in guinea-pig isolated vas deferens. Br. J. Pharmacol, 122, 285P.
20. SOTO, F., LAMBRECHT, G., NICKEL, P., STUHMER, W. & BUSCH, A.E. (1999). Antagonistic properties of the suramin analogue NF023 at heterologously expressed P2X receptors. Neuropharmacol., 38, 141-149.
21. TREZISE, D.J., BELL, N.J., KHAKH, B.S., MICHEL, A.D. & HUMPHREY, P.A. (1994). P2 purinoceptor antagonist properties of pyridoxal-5-phosphate. Eur. J. Pharmacol., 259, 295-300.
22. TODOROV, L.D., MIHAYLOVA-TODOROVA, S., CRAVISO, G.L., BJUR, R.A. & WESTFALL, D.P. (1996). Evidence for the differential release of the cotransmitters ATP and noradrenaline from sympathetic nerves of the guinea-pig vas deferens. J. Physiol., 496, 731-748.
23. TODOROV, L.D., MIHAYLOVA-TODOROVA, S., WESTFALL, T.D., SNEDDON, P., KENNEDY, C., BJUR, R.A. & WESTFALL, D.P. (1997). Neuronal release of soluble nucleotidases and their role in neurotransmitter inactivation. Nature, 387, 76-79.
24. URBANEK, E., NICKEL, P. & SCHLICKER, E. (1990). Antagonistic properties of four suramin-related compounds at vascular purine P2X receptors in the pithed rat. Eur. J. Pharmacol, 175, 207-210.
25. WESTFALL, T.D., KENNEDY, C. & SNEDDON, P. (1996). Enhancement of sympathetic purinergic neurotransmission in the guinea-pig isolated vas deferens by the novel ecto-ATPase inhibitor ARL 67156. Br. J. Pharmacol., 117, 867-872.
26. WESTFALL, T.D., KENNEDY, C. & SNEDDON, P. (1997). The effect of the novel ecto-ATPase inhibitor ARL 67156 on contractile responses to nerve stimulation and to drugs in guinea-pig urinary bladder. Eur. J. Pharmacol., 329, 169-174.
27. ZIMMERMANN, H. (1996). Biochemistry, localisation and functional roles of ecto-nucleotidases in the nervous system. Prog. Neurobiol., 49, 589-618.
28. ZIMMERMANN, H. (1999). Two families of ectonucleotidases: molecular structures, catalytic properties and a search for function. Trends Pharmacol. Sci., 20, 231-236.
29. ZIYAL, R., ZIGANSHIN, A.U., NICKEL, P., ARDANUY, U., MUTSCHLER, E., LAMBRECHT, G. & BURNSTOCK, G. (1997). Vasoconstrictor responses via P2X-receptors are selectively antagonised by NF023 in rabbit isolated aorta and saphenous artery. Br. J. Pharmacol., 120, 954-960.